Fundamental Analysis of Effector Therapeutics Inc - Growth / Value Index


EFTR - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 5.00
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -28.64 -97.36 -83626.24 %
Price to Book -443.86 -603.82 -189.26 % 7.90
Price to Sales 6121.93 0 0 %
Enterprise Value to EBITDA Multiple -0.393 -106.29 -81804.72 %


EFTR - Profitability Highlights

Profitability Analysis

   Tsr Profitability Index - Very Poor Score of 5.00
   Piotroski F Score - Very Poor Value of 2.0
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 0 0 0 % -1068.20
Return On Asset -148.43 -174.95 99.78 % -32.56
Net Profit Margin -21376.54 0 0 % 0
Operating Profit Margin -20777.78 0 0 % 0
EBITDA Margin -20741.98 0 0 % 0


Highlights
Market Cap7527.06 K
Enterprise Value13197.06 K
Price/Book TTM-443.86
Outstanding Share4704.41 K
Float/ Outstanding Share76.39%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score2.00
Altman Z Score-17.72
Sloan Ratio-0.252
Peter Lynch Fair Value0


EFTR - Growth Highlights

Growth Analysis

   Tsr Growth Index - Very Poor Score of 5.00
   Quarterly sales in last 5 Quarter is trending down
   Annual sales in last 3 years is trending down
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 162000 100.00 % 100.00 %
Gross Profit -111000.00 103.17 % 6.67 %
EBITDA -33602.00 K 61.66 % 2.32 %
Net Profit -34630.00 K 58.57 % 3.23 %
EPS -0.056 99.88 % NA


EFTR - Stability Highlights

Stability Analysis

   Debt to equity ratio has decreased and is lowest in last three years
   Tsr Stability Index - Very Poor Score of 5.00
   Altman Z Score of -17.68 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -11.58
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio -3.55 -168.31 % 22.94
Cash Ratio 0.712 -32.13 %
Quick Ratio 0 0 % 1.03
Shareholders Equity -28.21 -310.52 %
Debt to EBITDA -0.623 -62750.15 %


Historical Valuation Ratios of Effector Therapeutics Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Effector Therapeutics Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Effector Therapeutics Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Effector Therapeutics Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)